Skip to main content
. 2008 Apr 23;2008(2):CD003432. doi: 10.1002/14651858.CD003432.pub2
Study Reason for exclusion
Basse 2003 RCT on gastrointestinal recovery after laparoscopic versus open colonic resection (n=32). Includes also patients with benign disease. No follow‐up.
Basse 2005 RCT on functional recovery after laparoscopic versus open colonic resection (n=60). Includes also patients with benign disease. No follow‐up.
Bohm 1999 RCT on liver and renal function after laparoscopic compared to open colorectal resection for cancer. No follow‐up.
Braga 2002 a RCT on short‐term outcome after laparoscopic vs open colorectal resection for cancer. Patients are also included in Brage 2005.
Braga 2002 b RCT on immune responses and metabolism in laparoscopic versus open colorectal surgery (n=79). No follow‐up.
Danelli 2002 RCT on temperature control and recovery of bowel function after laparoscopic and conventional colorectal surgery (n=44). No follow‐up. Includes also benign disease, no separate data for cancer resections.
Delgado 2001 RCT on acute phase responses before and after laparoscopic versus open colectomy for cancer (n=97). No follow‐up.
Guillou 2005 did not describe any of the long‐term outcomes sought in this analysis or because patients were also included in another article or ongoing trial
Hewitt 1998 RCT on immune responses in laparoscopic‐assisted versus open surgery for colorectal cancer (n=25). No follow‐up.
Hildebrandt 2003 RCT on stress responses in laparoscopic and open colonic resections (n=42). Includes also patients with benign disease. No follow‐up.
Hu 2003 RCT on immune responses in laparoscopic versus open total mesorectal excision for rectal cancer (n=45). Patients were enrolled as part of the trail Zhou 2004. No follow‐up.
Janson 2004 RCT on the costs of laparoscopic versus open surgery for colonic cancer (n=210). Only data on costs are given. Patients were enrolled as part of the COLOR trial.
Jayne 2005 RCT on bladder and sexual function following laparoscopic‐assisted versus open colorectal resection for cancer. Patients were enrolled as part of the CLASICC trial.
Kang 2004 RCT on perioperative and short‐term results in laparoscopic versus open colectomy (n=60). Includes also patients with benign disease. No follow‐up.
Kim 1998 RCT on spillage of tumour cells in the peritoneal cavity during laparoscopic versus conventional surgery for colorectal cancer (n=38). No follow‐up.
Lacy 1995 RCT on laparoscopic versus open colectomy for colon cancer. Preliminary short‐term results of the trial Lacy 2002. Data and patients are also included in Lacy 2002. No follow‐up.
Lacy 1998 RCT on port‐site metastases and recurrences after laparoscopic‐assisted versus open colectomy for cancer (n=91). Data and patients are also included in Lacy 2002.
Leung 2000 RCT on systemic cytokine responses after laparoscopic‐assisted versus open resection of rectosigmoid carcinoma (n=34). No follow‐up.
Leung 2003 RCT on immune responses after laparoscopically‐assisted versus open resection of rectosigmoid carcinoma (n=40). No follow‐up.
Neudecker 2002 RCT on peritoneal fibrinolytic capacity after laparoscopic and conventional colorectal resection for cancer (n=30) No follow‐up. Patients were enrolled as part of the LAPKON II trial.
Neudecker 2003 RCT on intravasal fibrinolytic activity after laparoscopic and conventional colorectal resection for cancer (n=30). No follow‐up. Patients were enrolled as part of the LAPKON II trial.
Neudecker 2005 RCT on fibrinolytic capacity after laparoscopic and conventional colorectal surgery for cancer (n=30). No follow‐up. Patients were enrolled as part of the LAPKON II trial.
Ordemann 2001 RCT on inflammatory responses after laparoscopic versus conventional colorectal resections for cancer (n=40). No follow‐up.
Ortiz 1996 RCT on early oral feeding after laparoscopic versus open colonic resections (n=40). Includes also patients with benign disease. No follow‐up.
Schwenk 1998 a RCT on postoperative ileus after laparoscopic compared to open colorectal resection for cancer (n=60). No follow‐up. Data and patients are included in Schwenk 2002.
Schwenk 1998 b RCT on pain and fatique after laparoscopic compare to open colorectal resection for cancer (n=60). No follow‐up. Data and patients are also included in Schwenk 2002.
Schwenk 1998 c RCT on quality of life after laparoscopic compared to open colorectal resection for cancer (n=60). No follow‐up. Data and patients are also included in Schwenk 2002.
Schwenk 1999 RCT on pulmonary function after laparoscopic compared to open colorectal resection for cancer (n=60). No follow‐up. Data and patients are also included in Schwenk 2002.
Schwenk 2002 RCT on short‐term outcome after laparoscopic compared to open colorectal resection for cancer (n=102). No follow‐up.
Stage 1997 RCT on short‐term outcome, immunologic parameters and pathological evaluation of the resected specimen after laparoscopic compared to open surgery for cancer (n=34). No follow‐up.
Tang 2001 RCT on systemic immunity in patients undergoing laparoscopically‐assisted versus open colectomy for colorectal cancer (n=236). No follow‐up.
Weeks 2002 RCT on quality‐of‐life after laparoscopic‐assisted colectomy versus open colectomy for colon cancer (n=428). Only data on quality‐of‐life, pain and hospital stay are given. Patients were enrolled as part of the COST trial.
Wu 2003 RCT on peritoneal and systemic immune responses after laparoscopic compared to open surgery for colon cancer (n=26). No follow‐up. Patients were enrolled as part of the COLOR trial.
Wu 2004 RCT on local and systemic angiogenic responses after laparoscopic compared to open surgery for colon cancer (n=26). No follow‐up Patients were enrolled as part of the COLOR trial.